Abstract
We have investigated the expression of c-myc in 24 ocular melanomas by immunohistochemistry, using two monoclonal antibodies raised against a midsequence portion of the c-myc product (6E10) and against the C-terminus (9E10). The results were compared with other putative prognostic factors, including tumour size, cell type, proliferation index (determined by flow cytometry), and ploidy, as well as immunohistochemical staining for HMB-45 and S-100 antigens. Staining, often focal, for c-myc was found in both the nucleus and the cytoplasm of a proportion of the cells in most tumours studied. Total cell staining for myc protein correlated with proliferative index in diploid tumours; seven out of nine aneuploid and mixed aneuploid/diploid cells showed strong staining in at least one cellular compartment. A positive correlation with myc expression was also found for HMB-45 staining, but not for cell type or staining for S-100. The results support the hypothesis that myc protein is involved in cellular proliferation in uveal melanomas and indicate that immunohistochemistry for myc antigen may be a useful prognostic marker in these tumours.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ariga H, Imamura Y, Iguchi-Ariga SMM (1989) DNA replication origin and transcriptional enhancer in c-myc gene share the c-myc protein binding sequences. EMBO J 8:4273–4279
Bishop JM (1987) The molecular genetics of cancer. Science 235:305–311
Classon M, Henriksson M, Sumegi J, Klein G, Hammaskjold ML (1987) Elevated c-myc expression facilitates the replication of SV40 DNA in human lymphoma cells. Nature 330:272–274
Crook T, Greenfield I. Howard J, Stanley M (1990) Alterations in growth properties of human papilloma virus type 16 immortalised human cervical keratinocyte cell line correlate with amplification and overexpression ofc-myc oncogene. Oncogene 5:619–622
Dang CV, McGuire M, Buckmire M, Lee WM (1989) Involvement of the ‘leucine zipper’ region in the oligomerization and transforming activity of human c-myc protein. Nature 337:664–666
Donoso LA, Augsberger JJ, Shields JA, Greenberg RA, Gamel J (1986) Metastatic uveal melanoma — correlation between survival time and cytomorphometry of primary tumours. Arch Ophthalmol 104:76–78
Egan K, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM (1988) Epidemiological aspects of uveal melanoma. Surv Ophthalmol 32:239–251
Gamel JW, Greenberg RA, McLean IW, Seddon JM, Albert DM, Naids RE, Folberg R, Donoso LA (1986) A clinically useful method for combining gross and microscopic measurements to select high-risk patients after enucleation for ciliochoroidal melanoma. Cancer 57:1341–1344
Glasgow BJ, Wen D-R, Al-Jitaei S, Cochran AJ (1987) Antibody to S-100 protein aids the separation of pagetoid melanoma from mammary and extramammary Paget's disease. J Cutan Pathol 14:223–226
Glasgow BJ, McCall LC, Foos RY (1990) HMB-45 antibody reactivity in pigmented lesions of the conjunctiva. Am J Ophthalmol 109:696–700
Iguchi-Ariga SMM, Itani T, Kiji Y, Ariga H (1987) Possible function of the c-myc product: promotion of cellular DNA replication. EMBO J 6:2365–2371
Iguchi-Ariga SMM, Itani T, Yamaguchi M, Ariga H (1987) C-myc protein can be substituted for SV40 T antigen in SV40 DNA replication. Nucleic Acids Res 15:4889–4899
Iguchi-Ariga SMM, Okazaki T, Itani T, Otaga M, Sato Y, Ariga H (1988) An initiation site of DNA replication with transcriptional enhancer activity present upstream of the c-myc gene. EMBO J 7:3135–3142
Lech K, Anderson K, Brent R (1988) DNA-bound Fos proteins activate transcription in yeast. Cell 52:179–184
Lorenz U, Sock E, Grummt F, Moelling K (1991) Analysis of DNA sequences present in complexes of v-Myc and cellular DNA. Oncogene 6:51–57
Meecham WJ, Char DN (1986) DNA content abnormalities and prognosis in uveal melanoma. Arch Ophthalmol 104:1626–1629
Ordonez NG, Xiaolong J, Hickey RC (1988) Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 90:385–390
Paul EV, Parnell L, Fraker M (1962) Prognosis of malignant melanoma of the choroid and ciliary body. Int Ophthalmol Clin 2:387–402
Rennie IG, Rees RC, Parsons MA, Lawry J, Cottam D (1989) Estimation of DNA content in uveal melanomas by flow cytometry. Eye 3:611–617
Royds JA, Sharrard RM, Wagner B, Polacarz SV (1990) Ultrastructural immunocytochemistry for c-myc expression in colorectal neoplasia. J Pathol 161:343A
Royds JA, Sharrard RM, Wagner B, Polacarz SV (1992) Cellular localisation of c-myc product in human colorectal epithelial neoplasia. J Pathol 166:225–233
Rustgi AK, Dyson N, Bernards R (1991) Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352: 541–544
Shammas HF, Blodi FC (1977) Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 95:63–69
Sisley K, Rennie IG, Cottam DW, Potter AM, Potter CW, Rees RC (1990) Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8. Genes, Chromosomes and Cancer 2:205–209
Smoller BR, McNutt NS, Hsu A (1989) HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma. Am J Surg Pathol 13:680–684
Author information
Authors and Affiliations
Additional information
Sponsored by grants from the Yorkshire Cancer Research Campaign and the Special Trustees for the Former United Sheffield Hospitals (Grant no. 87221)
Correspondence to: J.A. Royds
Rights and permissions
About this article
Cite this article
Royds, J.A., Sharrard, R.M., Parsons, M.A. et al. C-myc oncogene expression in ocular melanomas. Graefe's Arch Clin Exp Ophthalmol 230, 366–371 (1992). https://doi.org/10.1007/BF00165947
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00165947